HCA Healthcare, Inc. $HCA Stock Position Decreased by HB Wealth Management LLC

Key Points

• HB Wealth Management LLC reduced its stake in HCA Healthcare by 13.8%, now holding 5,275 shares valued at approximately $2.02 million.
• HCA Healthcare reported a quarterly EPS of $6.84, surpassing the consensus estimate of $6.20, with quarterly revenue reaching $18.61 billion.
• The company announced a quarterly dividend of $0.72 per share, resulting in an annualized yield of 0.7% and a payout ratio of 12.11%.

HB Wealth Management LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 13.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,275 shares of the company's stock after selling 848 shares during the period. HB Wealth Management LLC's holdings in HCA Healthcare were worth $2,021,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HCA. Brighton Jones LLC bought a new position in HCA Healthcare in the 4th quarter worth about $1,021,000. Merit Financial Group LLC grew its position in HCA Healthcare by 109.9% in the 1st quarter. Merit Financial Group LLC now owns 3,293 shares of the company's stock worth $1,138,000 after purchasing an additional 1,724 shares during the last quarter. RFG Advisory LLC bought a new position in HCA Healthcare in the 1st quarter worth about $204,000. Whipplewood Advisors LLC grew its position in HCA Healthcare by 95.1% in the 1st quarter. Whipplewood Advisors LLC now owns 201 shares of the company's stock worth $69,000 after purchasing an additional 98 shares during the last quarter. Finally, Ullmann Wealth Partners Group LLC grew its position in HCA Healthcare by 1.3% in the 1st quarter. Ullmann Wealth Partners Group LLC now owns 6,890 shares of the company's stock worth $2,381,000 after purchasing an additional 88 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $426.81 on Friday. The company has a market cap of $99.87 billion, a PE ratio of 17.94, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $429.43. The firm has a 50 day simple moving average of $395.62 and a 200 day simple moving average of $371.70.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on HCA shares. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Wells Fargo & Company decreased their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Bank of America increased their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday, September 10th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Finally, Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and an average target price of $407.75.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.